Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling-Reference-Cited by-同舟云学术

Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling

Published:2012-10-22 Issue:11 Volume:33 Page:1359-1371
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Li Guo-fu,Wang Kun,Chen Rui,Zhao Hao-ru,Yang Jin,Zheng Qing-shan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps2012103.pdf

Reference67 articles.

1. Cruickshank JM . Beta-blockers and heart failure. Indian Heart J 2010; 62: 101–10.

2. de Groote P, Ennezat PV, Mouquet F . Bisoprolol in the treatment of chronic heart failure. Vasc Health Risk Manag 2007; 3: 431–9.

3. McGavin JK, Keating GM . Bisoprolol: a review of its use in chronic heart failure. Drugs 2002; 62: 2677–96.

4. Papadopulos DP, Papademetriou V . Low-dose fixed combination of bisoprolol /hydrochlorothiazide as first line for hypertension: a review of the rationale and clinical evidence. Angiology 2009; 60: 601–7.

5. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9–13.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment;Toxics;2023-10-21

2. Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease;Scientific Reports;2023-02-15

3. Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling;Pharmaceutics;2022-12-05

4. Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib;Clinical Pharmacology in Drug Development;2022-01-07

5. Reproducing prolonged time to peak bisoprolol concentration by PBPK modeling with lysosomal trapping in enterocytes;CPT: Pharmacometrics & Systems Pharmacology;2022-01